Answers are grounded in this paper and cite their sources.
Melatonin is characterized by significant antioxidant capacity. It and its metabolites directly neutralize reactive oxygen and nitrogen species, inhibit lipid peroxidation, and stimulate the activity of certain enzymatic antioxidants, while simultaneously reducing the toxicity of metal ions. Melatonin stabilizes mitochondrial functions, reduces inflammatory mediators, and participates in neurogenesis and neuroprotection. Due to these mechanisms, it is associated with the prevention of certain pathological conditions related to oxidative stress, including neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, ischemic stroke, cardiovascular diseases, and others. In the present study, it was found that melatonin, at concentrations of 150 µM, 100 µM, 50 µM, 10 µM, and 5 µM, exhibits a pronounced, statistically significant, concentration-dependent neuroprotective effect in various models of damage to isolated rat brain synaptosomes, mitochondria, and microsomes. At a concentration of 1 µM, it does not exhibit a statistically significant inhibitory effect on MAO-A/B isoforms or on certain isoforms of the cytochrome P450 system: CYP1A2, CYP2D6, and CYP3A4.
No takes yet. Share an insight, caveat, or question.
Kondeva-Burdina et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: